Pages that link to "Q35101694"
Jump to navigation
Jump to search
The following pages link to Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K (Q35101694):
Displaying 9 items.
- Mouse lung-adapted mutation of E190G in hemagglutinin from H5N1 influenza virus contributes to attenuation in mice. (Q30375832) (← links)
- Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates. (Q35860081) (← links)
- Rates and effectiveness of antiviral use among hospitalized influenza patients (Q38476530) (← links)
- A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4. (Q38625030) (← links)
- Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells (Q40044615) (← links)
- Role of R292K mutation in influenza H7N9 neuraminidase toward oseltamivir susceptibility: MD and MM/PB(GB)SA study (Q40513178) (← links)
- A rapid LC-MS/MS quantification of peramivir using a simple and inexpensive sample precipitation: application to PK. (Q41474937) (← links)
- Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. (Q42199847) (← links)
- Computational analysis of the receptor binding specificity of novel influenza A/H7N9 viruses. (Q54210967) (← links)